US Stock MarketDetailed Quotes

Enliven Therapeutics (ELVN)

Watchlist
  • 41.540
  • -0.710-1.68%
Close May 22 16:00 ET
  • 41.500
  • -0.040-0.10%
Post 19:56 ET
2.53BMarket Cap-25.33P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Enliven Therapeutics (ELVN) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
20.04%-19.29M
3.95%-70.3M
7.93%-15.84M
-8.91%-13.28M
16.53%-17.06M
-3.28%-24.13M
-19.46%-73.19M
-37.82%-17.2M
23.29%-12.19M
-69.60%-20.44M
Net income from continuing operations
17.23%-23.63M
-16.48%-103.69M
-27.99%-29.67M
12.99%-20.15M
-26.99%-25.34M
-25.53%-28.54M
-24.36%-89.02M
-19.67%-23.18M
-11.49%-23.16M
-19.31%-19.95M
Operating gains losses
----
863.64%106K
----
----
----
----
--11K
----
----
----
Depreciation and amortization
-81.08%14K
-17.03%263K
-42.50%46K
-22.50%62K
3.85%81K
-6.33%74K
6.73%317K
2.56%80K
2.56%80K
5.41%78K
Other non cash items
9.41%93K
163.83%353K
13.58%92K
1,171.43%89K
112.08%87K
7.59%85K
-280.72%-553K
3.85%81K
--7K
---720K
Change In working capital
-37.58%-3.43M
75.31%-1.12M
339.02%1.22M
-103.15%-157K
107.14%313K
46.15%-2.5M
-424.13%-4.54M
-109.33%-510K
58.25%4.99M
-455.27%-4.38M
-Change in prepaid assets
1,183.55%1.65M
76.82%-1.11M
-229.48%-694K
-82.25%139K
83.72%-398K
95.83%-152K
-28.76%-4.77M
-68.87%536K
132.34%783K
-850.00%-2.45M
-Change in payables and accrued expense
-119.08%-4.98M
-42.88%321K
308.53%2M
-104.80%-206K
143.00%798K
-150.00%-2.28M
-89.62%562K
-125.15%-961K
40.90%4.29M
-304.18%-1.86M
-Change in other current liabilities
-40.58%-97K
-0.60%-337K
-7.06%-91K
-7.14%-90K
-4.82%-87K
16.87%-69K
-8.06%-335K
-7.59%-85K
63.32%-84K
-8,200.00%-83K
Cash from discontinued investing activities
Operating cash flow
20.04%-19.29M
3.95%-70.3M
7.93%-15.84M
-8.91%-13.28M
16.53%-17.06M
-3.28%-24.13M
-19.46%-73.19M
-37.82%-17.2M
23.29%-12.19M
-69.60%-20.44M
Investing cash flow
Cash flow from continuing investing activities
2,880.10%42.53M
-382.93%-173.84M
1,602.75%12.38M
-127.37%-4.06M
-445.34%-183.59M
107.98%1.43M
75.75%-36M
-98.12%727K
141.71%14.83M
77.78%-33.67M
Net PPE purchase and sale
--0
225.00%55K
--213K
104.55%1K
-6,850.00%-139K
0.00%-20K
70.47%-44K
--0
-37.50%-22K
97.73%-2K
Net investment purchase and sale
2,838.91%42.53M
-372.21%-173.9M
1,573.45%12.17M
-116.93%-4.06M
-320.15%-183.45M
108.10%1.45M
75.16%-36.83M
-98.12%727K
167.47%23.98M
71.17%-43.66M
Net other investing changes
----
----
----
----
----
----
--873K
--0
---9.13M
----
Cash from discontinued investing activities
Investing cash flow
2,880.10%42.53M
-382.93%-173.84M
1,602.75%12.38M
-127.37%-4.06M
-445.34%-183.59M
107.98%1.43M
75.75%-36M
-98.12%727K
141.71%14.83M
77.78%-33.67M
Financing cash flow
Cash flow from continuing financing activities
4,196.15%10.05M
64.36%218.87M
-98.44%623K
-132.95%-368K
11,991.81%218.38M
-99.74%234K
-43.16%133.17M
44,313.33%39.97M
362.82%1.12M
164.04%1.81M
Net common stock issuance
----
67.72%216.17M
--0
---458K
71,125.25%216.63M
--0
--128.88M
--39.19M
--0
---305K
Proceeds from stock option exercised by employees
4,196.15%10.05M
-31.92%2.92M
-8.04%721K
-81.29%209K
-17.05%1.75M
-13.33%234K
973.18%4.28M
771.11%784K
3,889.29%1.12M
1,397.16%2.11M
Net other financing activities
----
---217K
---98K
----
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
4,196.15%10.05M
64.36%218.87M
-98.44%623K
-132.95%-368K
11,991.81%218.38M
-99.74%234K
-43.16%133.17M
44,313.33%39.97M
362.82%1.12M
164.04%1.81M
Net cash flow
Beginning cash position
-20.35%98.9M
23.93%124.17M
1.05%101.73M
23.23%119.44M
-31.84%101.71M
23.93%124.17M
32.55%100.2M
36.23%100.68M
-22.93%96.93M
-48.92%149.22M
Current changes in cash
248.17%33.29M
-205.42%-25.28M
-112.07%-2.84M
-572.13%-17.71M
133.91%17.73M
-145.83%-22.47M
-2.56%23.98M
-10.64%23.5M
107.23%3.75M
68.57%-52.29M
End cash Position
29.97%132.18M
-20.35%98.9M
-20.35%98.9M
1.05%101.73M
23.23%119.44M
-31.84%101.71M
23.93%124.17M
23.93%124.17M
36.23%100.68M
-22.93%96.93M
Free cash flow
20.11%-19.29M
3.79%-70.46M
7.93%-15.84M
-8.70%-13.28M
15.86%-17.2M
-3.28%-24.15M
-19.24%-73.24M
-37.67%-17.2M
23.22%-12.22M
-68.39%-20.44M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 20.04%-19.29M3.95%-70.3M7.93%-15.84M-8.91%-13.28M16.53%-17.06M-3.28%-24.13M-19.46%-73.19M-37.82%-17.2M23.29%-12.19M-69.60%-20.44M
Net income from continuing operations 17.23%-23.63M-16.48%-103.69M-27.99%-29.67M12.99%-20.15M-26.99%-25.34M-25.53%-28.54M-24.36%-89.02M-19.67%-23.18M-11.49%-23.16M-19.31%-19.95M
Operating gains losses ----863.64%106K------------------11K------------
Depreciation and amortization -81.08%14K-17.03%263K-42.50%46K-22.50%62K3.85%81K-6.33%74K6.73%317K2.56%80K2.56%80K5.41%78K
Other non cash items 9.41%93K163.83%353K13.58%92K1,171.43%89K112.08%87K7.59%85K-280.72%-553K3.85%81K--7K---720K
Change In working capital -37.58%-3.43M75.31%-1.12M339.02%1.22M-103.15%-157K107.14%313K46.15%-2.5M-424.13%-4.54M-109.33%-510K58.25%4.99M-455.27%-4.38M
-Change in prepaid assets 1,183.55%1.65M76.82%-1.11M-229.48%-694K-82.25%139K83.72%-398K95.83%-152K-28.76%-4.77M-68.87%536K132.34%783K-850.00%-2.45M
-Change in payables and accrued expense -119.08%-4.98M-42.88%321K308.53%2M-104.80%-206K143.00%798K-150.00%-2.28M-89.62%562K-125.15%-961K40.90%4.29M-304.18%-1.86M
-Change in other current liabilities -40.58%-97K-0.60%-337K-7.06%-91K-7.14%-90K-4.82%-87K16.87%-69K-8.06%-335K-7.59%-85K63.32%-84K-8,200.00%-83K
Cash from discontinued investing activities
Operating cash flow 20.04%-19.29M3.95%-70.3M7.93%-15.84M-8.91%-13.28M16.53%-17.06M-3.28%-24.13M-19.46%-73.19M-37.82%-17.2M23.29%-12.19M-69.60%-20.44M
Investing cash flow
Cash flow from continuing investing activities 2,880.10%42.53M-382.93%-173.84M1,602.75%12.38M-127.37%-4.06M-445.34%-183.59M107.98%1.43M75.75%-36M-98.12%727K141.71%14.83M77.78%-33.67M
Net PPE purchase and sale --0225.00%55K--213K104.55%1K-6,850.00%-139K0.00%-20K70.47%-44K--0-37.50%-22K97.73%-2K
Net investment purchase and sale 2,838.91%42.53M-372.21%-173.9M1,573.45%12.17M-116.93%-4.06M-320.15%-183.45M108.10%1.45M75.16%-36.83M-98.12%727K167.47%23.98M71.17%-43.66M
Net other investing changes --------------------------873K--0---9.13M----
Cash from discontinued investing activities
Investing cash flow 2,880.10%42.53M-382.93%-173.84M1,602.75%12.38M-127.37%-4.06M-445.34%-183.59M107.98%1.43M75.75%-36M-98.12%727K141.71%14.83M77.78%-33.67M
Financing cash flow
Cash flow from continuing financing activities 4,196.15%10.05M64.36%218.87M-98.44%623K-132.95%-368K11,991.81%218.38M-99.74%234K-43.16%133.17M44,313.33%39.97M362.82%1.12M164.04%1.81M
Net common stock issuance ----67.72%216.17M--0---458K71,125.25%216.63M--0--128.88M--39.19M--0---305K
Proceeds from stock option exercised by employees 4,196.15%10.05M-31.92%2.92M-8.04%721K-81.29%209K-17.05%1.75M-13.33%234K973.18%4.28M771.11%784K3,889.29%1.12M1,397.16%2.11M
Net other financing activities -------217K---98K----------------------------
Cash from discontinued financing activities
Financing cash flow 4,196.15%10.05M64.36%218.87M-98.44%623K-132.95%-368K11,991.81%218.38M-99.74%234K-43.16%133.17M44,313.33%39.97M362.82%1.12M164.04%1.81M
Net cash flow
Beginning cash position -20.35%98.9M23.93%124.17M1.05%101.73M23.23%119.44M-31.84%101.71M23.93%124.17M32.55%100.2M36.23%100.68M-22.93%96.93M-48.92%149.22M
Current changes in cash 248.17%33.29M-205.42%-25.28M-112.07%-2.84M-572.13%-17.71M133.91%17.73M-145.83%-22.47M-2.56%23.98M-10.64%23.5M107.23%3.75M68.57%-52.29M
End cash Position 29.97%132.18M-20.35%98.9M-20.35%98.9M1.05%101.73M23.23%119.44M-31.84%101.71M23.93%124.17M23.93%124.17M36.23%100.68M-22.93%96.93M
Free cash flow 20.11%-19.29M3.79%-70.46M7.93%-15.84M-8.70%-13.28M15.86%-17.2M-3.28%-24.15M-19.24%-73.24M-37.67%-17.2M23.22%-12.22M-68.39%-20.44M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +10.09%
Sample Name
Sample Code
 +8.38%
Sample Name
Sample Code
 +7.98%
4
United States Oil Fund LP
USO
+6.44%
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
+5.55%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +7.60%
Sample Name
Sample Code
 +7.37%
Sample Name
Sample Code
 +6.61%
4
United Microelectronics
UMC
+5.93%
5
Tencent Music
TME
+4.01%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 21, Eastern Time, according to Iran's Labor News Agency (ILNA), citing Al Arabiya television, the United States and Iran have reached Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -